Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)

被引：0

作者：

Pia Ostergaard

Michael A Simpson

Fiona C Connell

Colin G Steward

Glen Brice

Wesley J Woollard

Dimitra Dafou

Tatjana Kilo

Sarah Smithson

Peter Lunt

Victoria A Murday

Shirley Hodgson

Russell Keenan

Daniela T Pilz

Ines Martinez-Corral

Taija Makinen

Peter S Mortimer

Steve Jeffery

Richard C Trembath

Sahar Mansour

机构：

[1] Medical Genetics Unit,Division of Genetics and Molecular Medicine

[2] Biomedical Sciences,Department of Clinical Genetics

[3] St. George's University of London,Department of Clinical Genetics

[4] King's College London School of Medicine,Department of Paediatric Haematology

[5] Guy's Hospital,Department of Cardiac and Vascular Sciences

[6] Clinical Genetics,undefined

[7] Guy's and St. Thomas' National Health Service (NHS) Foundation Trust,undefined

[8] Guy's Hospital,undefined

[9] Bone Marrow Transplant Unit,undefined

[10] Royal Hospital for Children,undefined

[11] South West Thames Regional Genetics Service,undefined

[12] St. George's University of London,undefined

[13] Haematology Unit,undefined

[14] The Children's Hospital at Westmead,undefined

[15] St Michael's Hospital,undefined

[16] Yorkhill Hospital,undefined

[17] Alderhey Children's Hospital,undefined

[18] Institute of Medical Genetics,undefined

[19] University Hospital of Wales,undefined

[20] Lymphatic Development Laboratory,undefined

[21] Cancer Research UK London Research Institute,undefined

[22] St. George's University of London,undefined

来源：

Nature Genetics | 2011年 / 43卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Sahar Mansour and colleagues report alterations in the transcription factor GATA2 in eight pedigrees with Emberger disorder, which is characterized by primary lymphedema and predispositon to acute myeloid leukemia. Most of the heterozygous variants lead to frameshift mutations and premature termination of GATA2.

引用

页码：929 / 931

页数：2

共 50 条

[21] Cooperating Transcription Factor Mutations in Acute Myeloid Leukemia (AML): Simultaneous Targeting of GATA2 and CEBPA
Greif, Philipp A.
ANNALS OF HEMATOLOGY, 2013, 92 : S40 - S41
[22] THE ROLE OF THE GATA2 TRANSCRIPTIONAL PROGRAM IN THE DEVELOPMENT OF ACUTE MYELOID LEUKEMIA
Gioacchino, Emanuele
de Pater, Emma
Touw, Ivo
de Looper, Hans
Strien, Paulette
Hoogenboezem, Remco
Bindels, Eric
Dzierzak, Elaine
Kaimakis, Polynikis
EXPERIMENTAL HEMATOLOGY, 2017, 53 : S104 - S104
[23] Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature
Kazenwadel, Jan
Secker, Genevieve A.
Liu, Yajuan J.
Rosenfeld, Jill A.
Wildin, Robert S.
Cuellar-Rodriguez, Jennifer
Hsu, Amy P.
Dyack, Sarah
Fernandez, Conrad V.
Chong, Chan-Eng
Babic, Milena
Bardy, Peter G.
Shimamura, Akiko
Zhang, Michael Y.
Walsh, Tom
Holland, Steven M.
Hickstein, Dennis D.
Horwitz, Marshall S.
Hahn, Christopher N.
Scott, Hamish S.
Harvey, Natasha L.
BLOOD, 2012, 119 (05) : 1283 - 1291
[24] GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations
Green, Claire L.
Tawana, Kiran
Hills, Robert K.
Boedoer, Csaba
Fitzgibbon, Jude
Inglott, Sarah
Ancliff, Phil
Burnett, Alan K.
Linch, David C.
Gale, Rosemary E.
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (05) : 701 - 705
[25] Primary Lymphedema and Viral Warts in GATA2 Haploinsufficiency
Botero, Juliana Perez
Rodriguez, Vilmarie
MAYO CLINIC PROCEEDINGS, 2017, 92 (03) : 482 - 482
[26] A RARE CASE OF EMBERGER SYNDROME CAUSED BY A DE NOVO MUTATION IN THE GATA2 GENE
Michelini, S.
Cardone, M.
Agga, M. Haag O.
Bruson, A.
Maltese, P. E.
Bonizzato, A.
Bertelli, M.
LYMPHOLOGY, 2016, 49 (01) : 15 - 20
[27] Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
Theis, F.
Corbacioglu, A.
Gaidzik, V. I.
Paschka, P.
Weber, D.
Bullinger, L.
Heuser, M.
Ganser, A.
Thol, F.
Schlegelberger, B.
Goehring, G.
Koehne, C-H
Germing, U.
Brossart, P.
Horst, H-A
Haase, D.
Goetze, K.
Ringhoffer, M.
Fiedler, W.
Nachbaur, D.
Kindler, T.
Held, G.
Luebbert, M.
Wattad, M.
Salih, H. R.
Krauter, J.
Doehner, H.
Schlenk, R. F.
Doehner, K.
LEUKEMIA, 2016, 30 (11) : 2248 - 2250
[28] High Frequency of GATA2 Mutations in Cytogenetically Normal Acute Myeloid Leukemia with Biallelic CEBPA Mutations Identified by Exome Sequencing
Dufour, Annika
Konstandin, Nikola
Ksienzyk, Bianka
Zellmeier, Evelyn
Benthaus, Tobias
Yaghmaie, Marjan
Graf, Alexander
Krebs, Stefan
Hauser, Andreas
Blum, Helmut
Kakadia, Purvi
Schneider, Stephanie
Braess, Jan
Woermann, Bernhard Josef
Berdel, Wolfgang E.
Buechner, Thomas
Hiddemann, Wolfgang
Spiekermann, Karsten
Bohlander, Stefan K.
Greif, Philipp A.
BLOOD, 2011, 118 (21) : 35 - 35
[29] Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
F Theis
A Corbacioglu
V I Gaidzik
P Paschka
D Weber
L Bullinger
M Heuser
A Ganser
F Thol
B Schlegelberger
G Göhring
C-H Köhne
U Germing
P Brossart
H-A Horst
D Haase
K Götze
M Ringhoffer
W Fiedler
D Nachbaur
T Kindler
G Held
M Lübbert
M Wattad
H R Salih
J Krauter
H Döhner
R F Schlenk
K Döhner
Leukemia, 2016, 30 : 2248 - 2250
[30] Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
Mir, Muhammad A.
Kochuparambil, Samith T.
Abraham, Roshini S.
Rodriguez, Vilmarie
Howard, Matthew
Hsu, Amy P.
Jackson, Amie E.
Holland, Steven M.
Patnaik, Mrinal M.
CANCER MEDICINE, 2015, 4 (04): : 490 - 499

← 1 2 3 4 5 →